PCI Biotech Holding ASA (PCIB) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.501x

Based on the latest financial reports, PCI Biotech Holding ASA (PCIB) has a cash flow conversion efficiency ratio of -0.501x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-6.26 Million ≈ $-659.15K USD) by net assets (Nkr12.52 Million ≈ $1.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

PCI Biotech Holding ASA - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how PCI Biotech Holding ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PCIB total debt and obligations for a breakdown of total debt and financial obligations.

PCI Biotech Holding ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PCI Biotech Holding ASA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Groupimo SA PA:ALIMO	0.026x
Sejahtera Bintang Abadi Textile Tbk JK:SBAT	-0.023x
Tan Delta Systems PLC LSE:TAND	-0.358x
Lytus Technologies Holdings PTV. Ltd. Common Shares NASDAQ:LYT	0.005x
Virpax Pharmaceuticals Inc NASDAQ:VRPX	3.142x
Stayble Therapeutics AB ST:STABL	-0.219x
Baltic Bridge S.A. WAR:WIS	N/A
M Winkworth PLC LSE:WINK	0.157x

Annual Cash Flow Conversion Efficiency for PCI Biotech Holding ASA (2008–2024)

The table below shows the annual cash flow conversion efficiency of PCI Biotech Holding ASA from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see PCIB market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr23.45 Million ≈ $2.47 Million	Nkr-13.76 Million ≈ $-1.45 Million	-0.587x	-53.00%
2023-12-31	Nkr39.04 Million ≈ $4.11 Million	Nkr-14.97 Million ≈ $-1.58 Million	-0.383x	+62.72%
2022-12-31	Nkr57.40 Million ≈ $6.04 Million	Nkr-59.04 Million ≈ $-6.21 Million	-1.029x	-71.35%
2021-12-31	Nkr113.79 Million ≈ $11.97 Million	Nkr-68.31 Million ≈ $-7.19 Million	-0.600x	-46.79%
2020-12-31	Nkr189.24 Million ≈ $19.91 Million	Nkr-77.39 Million ≈ $-8.14 Million	-0.409x	-24.85%
2019-12-31	Nkr254.83 Million ≈ $26.82 Million	Nkr-83.47 Million ≈ $-8.78 Million	-0.328x	-258.30%
2018-12-31	Nkr339.95 Million ≈ $35.77 Million	Nkr-31.08 Million ≈ $-3.27 Million	-0.091x	+87.51%
2017-12-31	Nkr41.84 Million ≈ $4.40 Million	Nkr-30.62 Million ≈ $-3.22 Million	-0.732x	+73.17%
2016-12-31	Nkr13.09 Million ≈ $1.38 Million	Nkr-35.69 Million ≈ $-3.76 Million	-2.728x	-267.80%
2015-12-31	Nkr44.28 Million ≈ $4.66 Million	Nkr-32.84 Million ≈ $-3.46 Million	-0.742x	+78.66%
2014-12-31	Nkr9.11 Million ≈ $959.06K	Nkr-31.67 Million ≈ $-3.33 Million	-3.475x	-427.45%
2013-12-31	Nkr43.40 Million ≈ $4.57 Million	Nkr-28.59 Million ≈ $-3.01 Million	-0.659x	-88.59%
2012-12-31	Nkr69.71 Million ≈ $7.34 Million	Nkr-24.35 Million ≈ $-2.56 Million	-0.349x	-69.72%
2011-12-31	Nkr92.53 Million ≈ $9.74 Million	Nkr-19.05 Million ≈ $-2.00 Million	-0.206x	-104.92%
2010-12-31	Nkr105.42 Million ≈ $11.09 Million	Nkr-10.59 Million ≈ $-1.11 Million	-0.100x	+79.07%
2009-12-31	Nkr35.08 Million ≈ $3.69 Million	Nkr-16.84 Million ≈ $-1.77 Million	-0.480x	-151.50%
2008-12-31	Nkr49.30 Million ≈ $5.19 Million	Nkr-9.41 Million ≈ $-990.10K	-0.191x	--

About PCI Biotech Holding ASA

OL:PCIB Norway Biotechnology

Market Cap

$274.95K

Nkr2.61 Million NOK

Market Cap Rank

#30732 Global

#273 in Norway

Share Price

Nkr0.07

Change (1 day)

-39.13%

52-Week Range

Nkr0.07 - Nkr1.99

All Time High

Nkr86.30